Synth-Med Biotechnology
Synth-Med Biotechnology is dedicated to revolutionizing drug delivery systems through innovative technologies such as smart blood and erythrocyte-based therapeutics. Their mission is to develop precise, biocompatible delivery vehicles to treat neurological diseases, cancer, and other health conditions, aiming to save lives and improve patient outcomes. The company collaborates with leading institutions and has received recognition for its groundbreaking work in medical technology.
Industries
Nr. of Employees
small (1-50)
Products
Erythrocyte-derived drug delivery platform
A modular delivery platform that transforms red blood cells into nano-carriers for targeted delivery of proteins, small molecules, peptides, and nucleic acids with reported applications in neuroscience and oncology.
Erythrocyte-derived drug delivery platform
A modular delivery platform that transforms red blood cells into nano-carriers for targeted delivery of proteins, small molecules, peptides, and nucleic acids with reported applications in neuroscience and oncology.
Services
Preclinical development and platform optimization
Preclinical efficacy testing in animal models and computational/experimental optimization of erythrocyte-derived delivery systems.
Preclinical development and platform optimization
Preclinical efficacy testing in animal models and computational/experimental optimization of erythrocyte-derived delivery systems.
Expertise Areas
- Erythrocyte-based drug delivery
- Blood–brain barrier delivery
- Oncology therapeutic delivery
- Membrane and lipid engineering
Key Technologies
- Erythrocyte-derived carriers
- Cell membrane engineering
- Hybrid erythrocyte liposomes
- Nanomanipulation of membranes